Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study

Are Neutrophil/Lymphocyte and Platelet/Lymphocyte Rates in Patients with Non-Small Cell Lung Cancer Associated with Treatment Response and Prognosis?

“…NLR has also been previously found to independently predict outcomes in non-malignant disease such as chronic kidney disease (Kocyigit et al, 2013) and ST-elevated myocardial infarction (Kaya et al, 2013), in which the systemic inflammation response has been accused as a major contributing factor. These findings emphasize the use of NLR as a potential biomarker of the systemic inflammatory response.…”

Neutrophil/lymphocyte ratio is associated with right ventricular dysfunction in patients with acute inferior ST-segment elevation myocardial infarction

“…The NLR has been evaluated in coronary artery disease and acute coronary syndromes [25][26][27]. Kaya et al [28] evaluated the role of the NLR in patients with STEMI undergoing PCI and found that NLR is an independent predictor of both inhospital and long-term adverse outcomes. Arbel et al [29] showed that STEMI patients with high NLR had lower ejection fraction and more complications during their index hospitalization.…”

Neutrophil/Lymphocyte Ratio Can Predict Postoperative Mortality in Patients with Chronic Thromboembolic Pulmonary Hypertension

“…8) It is now considered to be a distal vasculopathy, in which structural changes caused by vascular remodeling and inflammation play a major role. [6][7][8][9][10][11][12][13][14][15][16][17][18][19] However, the pathophysiologic mechanism of increased PVR has not been well clarified so far.…”

“…The neutrophil/lymphocyte ratio (NLR) is a new inflammatory biomarker and can be used as an indicator of systemic inflammation in many disease. [10][11][12] The aim of our study was to investigate clinical importance of NLR in patients with CTEPH.…”